{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:19:01Z","timestamp":1793229541362,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cpcardiol.2024.102880","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T21:45:47Z","timestamp":1728596747000},"page":"102880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Left atrial appendage occlusion devices vs direct oral anticoagulants for atrial fibrillation: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Julia M.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael P.S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naieli M.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo E.E.","family":"Sbardelotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilton F.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2024.102880_bib0001","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.27.10.1765","article-title":"Acute stroke with atrial fibrillation: the Copenhagen stroke study","volume":"10","author":"J\u00f8rgensen","year":"1996","journal-title":"Stroke."},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102880_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"International Journal of Stroke"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0003","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.cpcardiol.2024.102880_bib0004","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s40265-015-0452-4","article-title":"Direct oral anticoagulants for the prevention of stroke in patients with nonvalvular atrial fibrillation: understanding differences and similarities","volume":"75","author":"Dobesh","year":"2015","journal-title":"Drugs"},{"issue":"9689","key":"10.1016\/j.cpcardiol.2024.102880_bib0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102880_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"PRAGUE-17 trial investigators. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131188","article-title":"Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes","volume":"389","author":"Melillo","year":"2023","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102880_bib0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jjcc.2023.07.015","article-title":"5-year stroke rates in nonvalvular atrial fibrillation after watchman compared to direct oral anticoagulants","volume":"83","author":"Khalid","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0009","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0010","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","year":"2023"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0012","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0013","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0014","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.repc.2020.07.021","article-title":"L Gon\u00e7alves Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke","volume":"40","author":"Paiva","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"19","key":"10.1016\/j.cpcardiol.2024.102880_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.027001","article-title":"Percutaneous left atrial appendage occlusion in comparison to non-vitamin k antagonist oral anticoagulant among patients with atrial fibrillation","volume":"11","author":"Noseworthy","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102880_bib0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102880_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029421","article-title":"Clinical outcomes of left atrial appendage occlusion versus switch of direct oral Antcoagulant in atrial fibrillation: a territory-wide retrospective analysis","volume":"12","author":"Ng","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102880_bib0019","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00392-021-01983-z","article-title":"Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation","volume":"111","author":"Ding","year":"2022","journal-title":"Clin Res Cardiol"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102880_bib0020","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.3390\/jcm12206693","article-title":"Left atrial appendage occlusion versus novel oral anticoagulation for stroke prevention in atrial fibrillation-one-year survival","volume":"12","author":"Tiosano","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2024.01.018","article-title":"Lower rate of major bleeding in very high-risk patients undergoing left atrial appendage occlusion: a propensity-matched comparison with direct oral anticoagulation","author":"Magnocavallo","year":"2024","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102880_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: A review and new insights","volume":"33","author":"Escudero-Mart\u00ednez","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102880_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/17474930221138707","article-title":"Poor collateral flow with severe hypoperfusion explains worse outcome in acute stroke patients with atrial fibrillation","volume":"18","author":"Yang","year":"2023","journal-title":"Int J Stroke"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102880_bib0024","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1016\/j.cpcardiol.2024.102880_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2014.8.paradigm","article-title":"Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage","volume":"121","author":"Le Roux","year":"2014","journal-title":"J Neurosurg"},{"issue":"36","key":"10.1016\/j.cpcardiol.2024.102880_bib0026","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Gelder","year":"2024","journal-title":"European Heart Journal"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.cpcardiol.2024.102880_bib0028","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0029","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0030","article-title":"Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study","author":"Waranugraha","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102880_bib0031","first-page":"e49827","article-title":"Comparison of the Efficacy and safety of left atrial appendage closure and direct oral anticoagulants for atrial fibrillation: a meta-analysis of randomized control trials and observational studies","volume":"15","author":"Wei","year":"2023","journal-title":"Cureus"},{"issue":"22","key":"10.1016\/j.cpcardiol.2024.102880_bib0032","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1161\/CIRCULATIONAHA.119.041346","article-title":"Comparison of events across bleeding scales in the ENGAGE AF-TIMI 48 Trial","volume":"140","author":"Bergmark","year":"2019","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.cpcardiol.2024.102880_bib0033","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.119.043318","article-title":"Anticoagulation-related major bleeding in patients with atrial fibrillation: looking behind the curtain","volume":"140","author":"Nelson","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102880_bib0034","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.cpcardiol.2024.102880_bib0035","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.3390\/jcm12237292","article-title":"Percutaneous Left Atrial Appendage Occlusion-Current Evidence and Future Directions","volume":"12","author":"Rotta Detto Loria","year":"2023","journal-title":"J Clin Med"},{"issue":"19","key":"10.1016\/j.cpcardiol.2024.102880_bib0036","first-page":"1543","article-title":"Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Controlled Trial. Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102880_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209687","article-title":"Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2024.102880_bib0038","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"Bassand","year":"2021","journal-title":"Blood Adv"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:50:33Z","timestamp":1732744233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624005152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0146280624005152"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102880","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage occlusion devices vs direct oral anticoagulants for atrial fibrillation: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102880"}}